Considerations in perioperative assessment of valproic acid coagulopathy

Area of Science:

• Pediatric Pharmacology
• Hematology
• Drug Safety

Background:

• Valproic acid (VPA) is a common antiepileptic medication for children.
• VPA has various therapeutic indications in pediatric populations.
• VPA can lead to coagulopathy, a bleeding disorder, posing clinical challenges.

Purpose of the Study:

• To review the incidence and severity of valproic acid-induced coagulopathy in children.
• To summarize current recommendations for managing VPA-related bleeding risks.
• To highlight the clinical implications for pre-operative assessment and patient care.

Main Methods:

• Systematic review of studies on VPA and coagulopathy.
• Analysis of documented cases of VPA-induced bleeding abnormalities.
• Compilation of expert guidelines and recommendations.

Main Results:

• Valproic acid is associated with an increased risk of coagulopathy in pediatric patients.
• The severity of VPA-induced coagulopathy can vary.
• Evidence-based recommendations for management are available but require wider implementation.

Conclusions:

• VPA-induced coagulopathy is a significant adverse effect requiring careful consideration in pediatric patients.
• Pre-operative evaluation and management strategies must account for VPA therapy.
• Further research may refine management protocols for VPA-related bleeding risks.